Recent content by Autumnly

XEN-496 Phase III trial is supposed to start before the end of 2020 Kv7 potassium channel modulator, is a proprietary pediatric formulation of the active ingredient ezogabine being developed for the treatment of epilepsy XEN1101 currently in Phase 2b “X-TOLE”, topline data is anticipated in...

Xenon Pharmaceuticals Receives FDA Feedback and is on Track to Initiate XEN496 Phase 3 Clinical Trial for the Treatment of KCNQ2-DEE Before Year-End October 8, 2020 Positive Opinion Received Supporting Orphan Medicinal Product Designation in Europe for XEN496 for the Treatment of KCNQ2-DEE

A New Buzz for Tinnitus—It’s in the Genes! Christopher R. Cederroth, PhD; Natalia Trpchevska, MD; Berthold Langguth, MD, PhD Novel Risk Loci in Tinnitus and Causal Inference With Neuropsychiatric Disorders Among Adults of European Ancestry Royce E. Clifford, MD, MPH; Adam X. Maihofer, MS...

BSHAA webinar video - Why is there no cure for tinnitus (with captions) - David Baguley, University of Nottingham

Is anyone taking part in any of these online support sessions by the BTA? An introduction to the solution-focused approach - free of charge, 9th Oct This session is all about the solution-focused approach to tinnitus, an effective and increasingly recognised therapy in psychological circles...

Association between Hyperacusis and Tinnitus Christopher R. Cederroth, Alessandra Lugo, Niklas K. Edvall, Andra Lazar, Jose-Antonio Lopez-Escamez, Jan Bulla, Inger Uhlen, Derek J. Hoare, David M. Baguley, Barbara Canlon, Silvano Gallus Abstract Hyperacusis was associated with any tinnitus...

They're uneducated in regards to hyperacusis and can't imagine a condition that makes normal everyday sounds dangerous to a person. Many ENTs rarely see people with hyperacusis, yet alone severe hyperacusis. Also: "Not many patients would be happy to hear that there’s a lag of about 17 years...

"Clinical advice rarely comprehends setbacks or the risk of making the condition worse. These findings provide key characteristics that need research to understand the underlying mechanisms. Importantly, clinicians should exercise caution at making such ambiguous claims as ‘everyday noise can’t...

A simple PDF file would be great. You can easily download it, skim through it and send it to other people. A video would be nice as well and Tinnitus Hub could share it via their social media accounts. I'd say simple and succinct but not too watered-down. If certain parts can't be shortened...

About the study duration of tinnitus isn't mentioned type of tinnitus isn't mentioned (e.g. chronic or intermittent) type of hyperacusis isn't specified type of hearing loss isn't mentioned didn't use THI or TFI but TQ they don't explain what they mean by "psychoeducation concerning tinnitus...

NIH awards researcher $972,613 for his drug research aimed at treating & preventing tinnitus Jianxin Bao, researcher and professor of anatomy and neurobiology at Northeast Ohio Medical University (NEOMED), received a federal grant to support further research and development of the prevention...

XEN1101 (in Phase 2) Dr. Pimstone continued, “Within our XEN1101 ‘X-TOLE’ Phase 2b clinical trial, as with other trials ongoing in our industry, we are seeing a significant reduction in new patient enrollment for numerous reasons related to the COVID-19 pandemic; therefore, we have adjusted...

I only know about the link I posted above, I'm not sure if they're going to upload the webinar. Yes, she mentioned that other researchers saw a reduction in tinnitus loudness in tDCS trials.

It's supposed to reduce tinnitus distress, not loudness.

Completely agree. Tinnitus subtypes research also seems based on the idea that we already have effective treatments and just have to find out who they work for so that we can sort people into groups. I remember reaching out to the authors saying that I'm worried this paper might harm severe...